港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫藥外包概念

2,435.829

-75.511-3.01%

漲家數：1

跌家數：7

平家數：- -

市盈率：- -

高：2,554.575

開：2,511.717

低：2,418.309

收：2,511.341

資料載入中...

每日賣空追蹤 | 藥明康德 07月28日賣空量成交35.08萬股，賣空比例為3.24%

每日賣空追蹤 | 藥明生物 07月28日賣空量成交690.9萬股，賣空比例為13.66%

每日賣空追蹤 | 金斯瑞生物科技 07月28日賣空量成交75.4萬股，賣空比例為3.51%

維亞生物盤中異動下午盤快速拉昇5.45%報1.740港元

抄底醫藥資產！上海國資瘋狂掃貨

昭衍新藥盤中異動下午盤大幅拉昇5.12%報25.650港元

康龍化成盤中異動早盤股價大漲5.15%

藥明康德漲1.88% 股價突破100港元大關

方達控股盤中異動股價大漲6.49%

麥格理：將藥明康德A股評級上調至跑贏大盤

廣生堂(300436.SZ)：乙肝治療一類創新藥奈瑞可韋GST-HG141的III期臨牀試驗首例受試者成功入組

生物股份(600201.SH)子公司獲得獸用生物製品臨牀試驗批件

藥明康德(02359.HK)7月25日斥資2699.76萬元回購30.3萬股A股

金斯瑞生物科技07月25日主力淨流出2704.4萬元散戶資金買入

藥明生物07月25日獲主力加倉1.8億元

昭衍新藥07月25日獲主力加倉465.3萬元

瑞普生物(300119.SZ)獲得獸用生物製品臨牀試驗批件

大和：維持藥明生物(02269.HK)“買入”評級盈喜勝預期

港股異動 | 中國抗體-B漲超19%，配股籌資3.69億港元用於臨牀試驗

港股異動 | 中國抗體-B(03681.HK)再漲超20% 公司配股籌資淨籌3.69億港元擬用於SM03臨牀試驗等項目

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1576/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":2435.8293,"timestamp":1754035689643,"preClose":2511.3406,"halted":0,"volume":128519186,"delay":0,"changeRate":-0.030068,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-75.51123,"latestTime":"08-01 16:00:00","open":2511.7168,"high":2554.5754,"low":2418.309,"amount":4349383561,"amplitude":0.05426,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1754271000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1754011800000,1754020800000],[1754024400000,1754035200000]],"pbRate":3.110517,"peRate":13.714712,"turnoverRate":0.011078,"increases":1,"decrements":7,"flats":0,"marketCap":562562882560,"floatMarketCap":224431559424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2554.5754,"amplitude":0.05426,"preClose":2511.3406,"low":2418.309,"pbRate":"3.110517","latestPrice":2435.8293,"volume":128519186,"delay":0,"open":2511.7168,"prevYearClose":1395.7731,"prevWeekClose":2461.148,"prevMonthClose":2511.341,"prevQuarterClose":1988.255,"fiveDayClose":2461.148,"twentyDayClose":2025.151,"sixtyDayClose":1657.443,"secType":"PLATE","market":"HK","turnoverRate":0.011078,"peRate":13.714712,"marketCap":562562882560,"floatMarketCap":224431559424,"timestamp":1754035689643,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":1,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554778601","title":"每日賣空追蹤 | 藥明康德 07月28日賣空量成交35.08萬股，賣空比例為3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554778601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554778601?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 16:30","pubTimestamp":1753691430,"startTime":"0","endTime":"0","summary":"药明康德北京时间07月28日，涨1.98%，卖空量成交35.08万股%，较上一交易日减少81.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728171848a4677025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728171848a4677025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","02359","LU0052750758.USD","LU2125910500.SGD","BK1583","BK1576","LU2242644610.SGD","BK1141","LU0320764599.SGD","LU1046422090.SGD","LU2045819591.USD"],"gpt_icon":0},{"id":"2554233722","title":"每日賣空追蹤 | 藥明生物 07月28日賣空量成交690.9萬股，賣空比例為13.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554233722","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554233722?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 16:30","pubTimestamp":1753691429,"startTime":"0","endTime":"0","summary":"药明生物北京时间07月28日，涨1.59%，卖空量成交690.9万股%，较上一交易日增加15.56%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728171832a6c5b0f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728171832a6c5b0f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0307460666.USD","LU0516422366.SGD","LU0572944931.SGD","LU0043850808.USD","LU1794554557.SGD","LU0140636845.USD","BK1521","IE00B0JY6N72.USD","LU0039217434.USD","LU1720050803.USD","LU0417516738.SGD","LU0516422952.EUR","02269","LU0856984785.SGD","LU0348735423.USD","LU0516422440.USD","LU0516423174.USD","LU0979878070.USD","BK1141","LU0359202008.SGD","LU0326950275.SGD","LU0052750758.USD","LU2039709279.SGD","SG9999002463.SGD","LU1242518857.USD","BK1610","LU0456827905.SGD","LU0348825331.USD","LU1880383366.USD","LU0181495838.USD","SG9999002562.SGD","LU0516423091.SGD","LU1242518931.SGD","LU0819121731.USD","BK1589","LU0456846285.SGD","LU0823426308.USD","LU0588546209.SGD","LU0320764599.SGD","LU0327786744.USD","LU0417516902.SGD","LU1688375341.USD","LU0359201612.USD","LU0708995583.HKD","LU0051755006.USD","LU0823426480.USD","BK1576"],"gpt_icon":0},{"id":"2554771555","title":"每日賣空追蹤 | 金斯瑞生物科技 07月28日賣空量成交75.4萬股，賣空比例為3.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554771555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554771555?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 16:30","pubTimestamp":1753691423,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技北京时间07月28日，涨1.12%，卖空量成交75.4万股%，较上一交易日减少62.93%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728171619a6c5af8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728171619a6c5af8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306685.HKD","01548","HK0000306701.USD","HK0000320223.HKD","BK1141","BK1583","BK1576","HK0000320264.USD"],"gpt_icon":0},{"id":"2554372501","title":"維亞生物盤中異動 下午盤快速拉昇5.45%報1.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554372501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554372501?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 15:12","pubTimestamp":1753686747,"startTime":"0","endTime":"0","summary":"2025年07月28日下午盘15时12分，维亚生物股票出现波动，股价快速拉升5.45%。截至发稿，该股报1.740港元/股，成交量1387.1万股，换手率0.65%，振幅5.45%。资金方面，该股资金流入1457.25万港元，流出821.796万港元。最近的财报数据显示，该股实现营业收入21.45亿港元，净利润1.81亿港元，每股收益0.0864港元，毛利7.42亿港元，市盈率20.50倍。维亚生物股票所在的生物技术行业中，整体涨幅为2.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281512279722aeb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281512279722aeb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","01873","BK1141"],"gpt_icon":0},{"id":"2554726758","title":"抄底醫藥資產！上海國資瘋狂掃貨","url":"https://stock-news.laohu8.com/highlight/detail?id=2554726758","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554726758?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 15:11","pubTimestamp":1753686675,"startTime":"0","endTime":"0","summary":"7月25日，港股上市的国产创新医疗器械龙头公司微创医疗发布公告：上实资本旗下上海生物医药并购基金，成为微创医疗的战略股东。事实上，这是在短短的一周内，上海国资在生物医药领域的第二次出手。层层穿透之后，万可欣生物的背后，也是上海国资。除了上海市级国资屡屡出手之外，上海区级的国资也在行动。上海汇资投资有限公司的控股股东，是上海徐汇区国资委。这是上海国资又一次悄悄地拿下了国内医药细分赛道的一块优质资产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728152835a4672dbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728152835a4672dbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1576","LU1046422090.SGD","BK1515","02359","LU0320764599.SGD","LU2242644610.SGD","BK1583","LU0708995583.HKD","LU0052750758.USD","603259","LU2045819591.USD","LU2125910500.SGD","00853","09939","BK1141"],"gpt_icon":0},{"id":"2554728724","title":"昭衍新藥盤中異動 下午盤大幅拉昇5.12%報25.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554728724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554728724?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 13:27","pubTimestamp":1753680462,"startTime":"0","endTime":"0","summary":"2025年07月28日下午盘13时27分，昭衍新药股票出现异动，股价大幅上涨5.12%。截至发稿，该股报25.650港元/股，成交量533.544万股，换手率4.48%，振幅7.99%。资金方面，该股资金流入6032.57万港元，流出4855.2万港元。昭衍新药股票所在的生物技术行业中，整体涨幅为1.34%。其相关个股中，北海康成-B、方达控股、三叶草生物-B涨幅较大，振幅较大的相关个股有北海康成-B、方达控股、奥星生命科技，振幅分别为20.51%、18.18%、14.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728132742a6c54369&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728132742a6c54369&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2554074201","title":"康龍化成盤中異動 早盤股價大漲5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554074201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554074201?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 10:52","pubTimestamp":1753671163,"startTime":"0","endTime":"0","summary":"2025年07月28日早盘10时52分，康龙化成股票出现异动，股价大幅拉升5.15%。截至发稿，该股报23.500港元/股，成交量1277.09万股，换手率4.34%，振幅5.15%。资金方面，该股资金流入1.53417亿港元，流出9454.71万港元。康龙化成股票所在的药品行业中，整体涨幅为1.91%。其相关个股中，恒瑞医药、泰凌医药、培力农本方涨幅较大，振幅较大的相关个股有泰凌医药、联康生物科技集团、德琪医药-B，振幅分别为8.20%、6.61%、6.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728105243a466c350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728105243a466c350&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1576","BK1141"],"gpt_icon":0},{"id":"2554742927","title":"藥明康德漲1.88% 股價突破100港元大關","url":"https://stock-news.laohu8.com/highlight/detail?id=2554742927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554742927?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 09:35","pubTimestamp":1753666530,"startTime":"0","endTime":"0","summary":"2025年07月28日早盘09时35分，药明康德股票出现异动，股价大幅拉升1.88%。截至发稿，该股报100.300港元/股，成交量81.4781万股，换手率0.21%，振幅1.93%。资金方面，该股资金流入4911.39万港元，流出2461.84万港元。药明康德股票所在的生物技术行业中，整体涨幅为0.68%。其中，药明康德以超85亿元净利润领跑；翰宇药业依靠技术平台实现国际突围，净利润大增1664％；微芯生物则借创新药商业化放量扭亏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728093530972221cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728093530972221cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU0708995583.HKD","LU0320764599.SGD","BK1141","LU0052750758.USD","LU2045819591.USD","LU2125910500.SGD","LU1046422090.SGD","LU2242644610.SGD","02359","BK1583"],"gpt_icon":0},{"id":"2554285747","title":"方達控股盤中異動 股價大漲6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554285747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554285747?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 09:35","pubTimestamp":1753666523,"startTime":"0","endTime":"0","summary":"2025年07月28日早盘09时35分，方达控股股票出现波动，股价急速拉升6.49%。资金方面，该股资金流入31.072万港元，流出6.608万港元。方达控股股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，方达控股、奥星生命科技、巨子生物涨幅较大，振幅较大的相关个股有奥星生命科技、方达控股、映恩生物-B，振幅分别为12.22%、9.74%、6.76%。方达控股公司简介：Frontage Holdings Corp是一家控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809352494be47d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809352494be47d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","01521","BK1583"],"gpt_icon":0},{"id":"2554743098","title":"麥格理：將藥明康德A股評級上調至跑贏大盤","url":"https://stock-news.laohu8.com/highlight/detail?id=2554743098","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554743098?lang=zh_tw&edition=fundamental","pubTime":"2025-07-27 23:59","pubTimestamp":1753631983,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MUCmain","LU1969619763.USD","LU0052750758.USD","LU2242644610.SGD","BK1141","LU2495084118.USD","BK1576","LU1046422090.SGD","LU1997245177.USD","LU0708995583.HKD","LU2045819591.USD","LU0320764599.SGD","LU1997244956.HKD","CNHmain","MCNHmain","LU0456842615.SGD","CYB","LU2488822045.USD","BK0216","603259","LU1997245094.SGD","BK1583","159982","UCmain","LU2328871848.SGD","399300","LU2125910500.SGD","02359"],"gpt_icon":0},{"id":"2554630017","title":"廣生堂(300436.SZ)：乙肝治療一類創新藥奈瑞可韋GST-HG141的III期臨牀試驗首例受試者成功入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2554630017","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554630017?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 17:51","pubTimestamp":1753437067,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广生堂 发布公告，公司创新药控股子公司福建广生中霖生物科技有限公司的在研乙肝治疗一类创新药奈瑞可韦GST-HG141的III期临床试验，已于2025年7月25日在树兰(杭州)医院完成首例受试者成功入组给药。2024年11月，GST-HG141的II期临床研究成果被全球肝病研究领域的权威专业学术机构美国肝病研究协会作为最新突破摘要形式接受并展示。2024年12月，GST-HG141被国家药品监督管理局药品审评中心纳入突破性治疗品种名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4134","159992","GST","III","03347","BK1583","BK1141","BK1161","06978","300436","BK1576","BK0239"],"gpt_icon":0},{"id":"2554757652","title":"生物股份(600201.SH)子公司獲得獸用生物製品臨牀試驗批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2554757652","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554757652?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 16:32","pubTimestamp":1753432351,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)发布公告，近日，公司全资子公司金宇保灵生物药品有限公司(简称“金宇保灵”)收到了农业农村部颁发的猫传染性腹膜炎mRNA疫苗临床试验批件(批件号：2025062)。猫传染性腹膜炎mRNA疫苗属于新型创新疫苗，公司率先攻克抗原设计及核酸疫苗产业化难点，成为全国首家获得猫传染性腹膜炎兽用核酸疫苗临床批件的公司，为公司后续兽用核酸疫苗发展奠定基础。兽用疫苗产品从前期研发到上市销售整个周期较长，项目研究开发进度、技术成果、后期产业化应用进程等尚存在一定不确定性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03347","BK1583","600201","BK0012","BK0185","BK0188","BK1576","BK0077","BK0046","BK0028","BK0196","BK0239"],"gpt_icon":0},{"id":"2554576997","title":"藥明康德(02359.HK)7月25日斥資2699.76萬元回購30.3萬股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2554576997","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554576997?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 16:32","pubTimestamp":1753432335,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","LU1997245177.USD","LU0708995583.HKD","399300","LU1046422090.SGD","LU2495084118.USD","603259","LU2045819591.USD","LU2125910500.SGD","BK1576","LU0052750758.USD","LU2242644610.SGD","159982","LU2328871848.SGD","LU1969619763.USD","LU1997244956.HKD","BK1141","02359","LU0320764599.SGD","LU1997245094.SGD","LU2488822045.USD","BK0216","LU0456842615.SGD"],"gpt_icon":0},{"id":"2554576244","title":"金斯瑞生物科技07月25日主力淨流出2704.4萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2554576244","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554576244?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 16:16","pubTimestamp":1753431365,"startTime":"0","endTime":"0","summary":"07月25日, 金斯瑞生物科技股价跌2.62%，报收17.84元，成交金额5.2亿元，换手率1.31%，振幅4.91%，量比0.78。金斯瑞生物科技今日主力资金净流出2704.4万元，上一交易日主力净流入313.0万元。该股近5个交易日上涨5.95%，主力资金累计净流入2112.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入8790.8万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725170127a462ffc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725170127a462ffc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01548","HK0000320223.HKD","BK1576","HK0000306701.USD","HK0000306685.HKD","HK0000320264.USD","BK1583","BK1141"],"gpt_icon":0},{"id":"2554764335","title":"藥明生物07月25日獲主力加倉1.8億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554764335","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554764335?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 16:15","pubTimestamp":1753431359,"startTime":"0","endTime":"0","summary":"07月25日, 药明生物股价涨5.53%，报收31.50元，成交金额28.3亿元，换手率2.21%，振幅8.71%，量比1.46。药明生物今日主力资金净流入1.8亿元，连续3日净流入，上一交易日主力净流入2.4亿元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为56.25%，平均涨幅为4.30%。该股近5个交易日上涨10.33%，主力资金累计净流入5.9亿元；近20日主力资金累计净流入8.9亿元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165918a462fe89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165918a462fe89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B0JY6N72.USD","LU0456827905.SGD","LU0417516738.SGD","LU1794554557.SGD","LU0326950275.SGD","LU0823426480.USD","LU0708995583.HKD","LU0516423174.USD","LU0043850808.USD","LU0456846285.SGD","LU2039709279.SGD","SG9999002562.SGD","LU0819121731.USD","LU0856984785.SGD","LU1720050803.USD","LU0140636845.USD","LU0051755006.USD","BK1576","LU0327786744.USD","LU0348735423.USD","LU0181495838.USD","02269","LU0307460666.USD","LU0052750758.USD","BK1141","LU0516422440.USD","LU0516422952.EUR","LU0516423091.SGD","LU0588546209.SGD","LU0979878070.USD","LU0039217434.USD","LU0359201612.USD","LU0320764599.SGD","LU1880383366.USD","LU0572944931.SGD","LU0823426308.USD","LU1242518857.USD","LU1242518931.SGD","SG9999002463.SGD","LU0359202008.SGD","LU0417516902.SGD","BK1589","LU1688375341.USD","BK1521","LU0348825331.USD","BK1610","LU0516422366.SGD"],"gpt_icon":0},{"id":"2554652377","title":"昭衍新藥07月25日獲主力加倉465.3萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554652377","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554652377?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 16:15","pubTimestamp":1753431336,"startTime":"0","endTime":"0","summary":"07月25日, 昭衍新药股价涨7.02%，报收24.40元，成交金额2.0亿元，换手率7.04%，振幅9.43%，量比1.33。昭衍新药今日主力资金净流入465.3万元，连续3日净流入，上一交易日主力净流入949.7万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为66.67%，平均涨幅为3.09%。该股近5个交易日上涨11.67%，主力资金累计净流入2834.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4747.7万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165048a462fa10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725165048a462fa10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2554542977","title":"瑞普生物(300119.SZ)獲得獸用生物製品臨牀試驗批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2554542977","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554542977?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 15:48","pubTimestamp":1753429739,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞普生物(300119.SZ)发布公告，近日，公司收到了农业农村部颁发的猪流行性腹泻病毒mRNA疫苗(RPS1903)临床试验批件(批件号：2025061)。此次获得的临床批件，是国内首个经济动物用mRNA疫苗临床批件。mRNA疫苗通过精准编码猪流行性腹泻病毒的关键抗原序列，进入机体后直接引导细胞合成抗原蛋白，从而激发强效免疫反应。与传统疫苗相比，mRNA疫苗在研发效率、免疫效果及生物安全风险防控等方面，具备明显优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0239","BK0070","BK1583","BK1141","300119","BK1576","03347"],"gpt_icon":0},{"id":"2554875141","title":"大和：維持藥明生物(02269.HK)“買入”評級 盈喜勝預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2554875141","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554875141?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 15:13","pubTimestamp":1753427633,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1880383366.USD","LU0140636845.USD","LU1242518931.SGD","LU0856984785.SGD","LU0456846285.SGD","LU2039709279.SGD","BK1521","IE00B0JY6N72.USD","LU0326950275.SGD","LU0051755006.USD","LU0327786744.USD","LU0979878070.USD","BK4080","LU0516422366.SGD","LU0039217434.USD","LU0359201612.USD","LU0588546209.SGD","LU0181495838.USD","LU0516422952.EUR","LU0516423091.SGD","LU1720050803.USD","LU1794554557.SGD","SG9999002463.SGD","LU0516423174.USD","LU0823426308.USD","LU0708995583.HKD","LU0348825331.USD","LU0819121731.USD","SG9999002562.SGD","LU0043850808.USD","LU0456827905.SGD","BK1589","LU0307460666.USD","ADC","LU0320764599.SGD","BK1610","LU0417516902.SGD","LU0572944931.SGD","BK1576","LU0359202008.SGD","LU0052750758.USD","LU0823426480.USD","BK1141","02269","LU0417516738.SGD","LU1242518857.USD","BK4231","LU0348735423.USD","LU0516422440.USD","LU1688375341.USD"],"gpt_icon":0},{"id":"1107966336","title":"港股異動 | 中國抗體-B漲超19%，配股籌資3.69億港元用於臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1107966336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107966336?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 11:34","pubTimestamp":1753414492,"startTime":"0","endTime":"0","summary":"7月25日，中国抗体-B盘中涨超19%，公司配股筹资净筹3.69亿港元，拟用于SM03临床试验等项目。消息面上，中国抗体公告，拟发行1.82亿股新股份，认购价为每股2.03港元。该决定乃经内部评估后作出，该评估确定需要补充早期疗效的证据以支持BLA的审批。公司对舒西利单抗获批准于中国上市仍具信心，已开始规划舒西利单抗用于治疗系统性红斑狼疮的新临床开发计划。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1321863.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","BK1576","BK4614","BK1141","BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2554675834","title":"港股異動 | 中國抗體-B(03681.HK)再漲超20% 公司配股籌資淨籌3.69億港元 擬用於SM03臨牀試驗等項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2554675834","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554675834?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 11:25","pubTimestamp":1753413958,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","BK1141","03347","BK1161","BK1583","BK1574","03681"],"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":8,"totalSize":255,"code":"91000000","status":"200"}]}}